Early MRIs Could Prevent Breast Cancer Deaths In Lymphoma Survivors

For female survivors of childhood Hodgkin’s lymphoma, undergoing MRI screenings early could reduce the chances of breast cancer death.

In a study conducted at the Princess Margaret Cancer Centre, researchers discovered that early MRI screenings could reduce mortality rates for females afflicted with childhood Hodgkin’s lymphoma (HL) who received chest radiation as part of their treatment. The findings implicate the importance of breast cancer screenings for female survivors who otherwise wouldn’t undergo the screenings at such a young age.

"If you are a young woman who was treated with radiation therapy to your chest as a teenager or child for HL, or for that matter chest radiation therapy for any reason, you should be having a conversation with your family doctor or your oncologist about whether to start breast cancer screening earlier than most women would," said Dr. David Hodgson, a radiation oncologist at the center.

Awareness is key

According to Dr. Hodgson, there may be thousands of Hodgkin’s lymphoma survivors in North America who underwent chest radiation treatment early in life but are unaware of the complications in adulthood. These potential risks make them eligible candidates for early MRI screenings, and the researchers in the study believe the screenings should take place as early as the age of 25.

"Many of these are women who received radiotherapy to more normal tissue or at higher doses than are used currently, but even for more recently treated patients, screening should reduce the risk of breast cancer death," said Dr. Hodgson.

Source: University Health Network

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap